$KD

The Gross Law Firm filed a class action against Ardent Health ($ARDT) alleging misrepresentation of accounts receivable collection and insufficient insurance coverage. Investors may qualify as lead plaintiffs.

The Gross Law Firm files class action against $KD over alleged materially false statements, inadequate internal controls, and delayed Q4 2025 filing.

Kyndryl faces securities fraud class action after CFO departure, SEC investigation, and filing delays spark 54.9% stock crash.

Schall Law Firm launches class action against $KD over alleged false statements and financial reporting failures affecting investors from August 2024 to February 2026.

Robbins LLP filed class action against $KD over alleged financial statement misstatements and internal control failures. Stock plunged 55% after SEC investigation disclosure.

Kyndryl ($KD) faces class action lawsuit after 55% stock decline following February disclosure of material weaknesses in internal controls and delayed 10-Q filing.

Rosen Law Firm files securities class action against $NAVN, alleging false IPO disclosures about sales expenses. Lead plaintiff deadline set for April 24, 2026.

Rosen Law Firm reminds Kyndryl investors of April 13, 2026 lead plaintiff deadline in securities fraud class action alleging false financial statements and control failures.

Kyndryl Holdings ($KD) plummeted 55% after disclosing ineffective controls, SEC scrutiny, and executive departures. Securities lawsuit filed; $2.4B in market value erased.

Kyndryl Holdings faces securities fraud lawsuit over internal control failures and executive departures. Stock crashed 55% after delayed 10-Q filing disclosure.

Law firm Kahn Swick & Foti files class action against $UGXX over failed Phase 3 trial for rare bone disease drug setrusumab. Investors can apply as lead plaintiffs by April 6.

Kahn Swick & Foti, LLC filed class action lawsuits against Navan, Kyndryl, and Ultragenyx for alleged securities disclosure violations. Lead plaintiff applications due April 24, 2026.

Grabar Law Office investigates shareholder claims against $CORT, $ITGR, $KD, and $MOH for alleged disclosure failures and fiduciary breaches spanning clinical trials, sales concealment, and cost trend non-disclosure.

Pomerantz Law Firm files class action against $KD over alleged securities fraud, triggered by SEC investigation, late filings, and executive departures.

Pomerantz Law Firm sues Varonis Systems over alleged securities fraud following October 2025 earnings miss that revealed 63.9% subscription revenue decline and 48.67% stock drop.

BlackRock TCP Capital faces class action lawsuit over 23.4% NAV collapse. Investors have until April 6, 2026, to join litigation.

Pomerantz Law Firm files class action against $DOOR alleging stock buybacks while concealing higher Owens Corning acquisition offers. Investor deadline: April 7, 2026.

Pomerantz Law Firm files class action against $FRMI over tenant termination of $150M construction agreement post-IPO, alleging securities fraud. March 6 deadline for investors.

Law firm Levi & Korsinsky filed securities class action against Kyndryl Holdings ($KD), alleging fraud. Investors must claim lead plaintiff status by April 13, 2026.

Kyndryl faces class action lawsuit alleging material misrepresentations about financial condition and internal controls. Stock fell 55% after disclosures of control weaknesses and executive departures.